Bortezomib (BTZ) prior to and as maintenance therapy after autologous stem cell transplant (ASCT) in multiple myeloma (MM): Long-term follow-up of a phase II study
Year: 2007
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: S. D. Goyal, G. Uy, J. F. DiPersio, R. Vij
Institution: Washington University in St. Louis
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2259941359
